Home Stock

Stock Research: Chong Kun Dang

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Chong Kun Dang

KSC:185750 KR7185750007
70
  • Value
    74
  • Growth
    19
  • Safety
    Safety
    63
  • Combined
    49
  • Sentiment
    92
  • 360° View
    360° View
    70
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Chong Kun Dang Pharmaceutical Corp manufactures and sells pharmaceuticals, including prescription and over-the-counter drugs, quasi-drugs, and health functional foods. The company operates in the pharmaceutical and healthcare industries, with products including antidiabetic treatments, cerebrovascular disease treatments, and OTC drugs like penzal. It sells products domestically and internationally. In the last fiscal year, the company had a market cap of $821 million, profits of $361 million, and revenue of $1074 million. The number of employees is not available.

more

ANALYSIS: With an Obermatt 360° View of 70 (better than 70% compared with alternatives), overall professional sentiment and financial characteristics for the stock Chong Kun Dang are above average. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Chong Kun Dang. The consolidated Value Rank has an attractive rank of 74, which means that the share price of Chong Kun Dang is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 74% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 63. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 92. But the consolidated Growth Rank has a low rank of 19, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 81 of its competitors have better growth. ...read more

more
Strongest Rank Capital Growth
Weakest Rank Sentiment
Country South Korea
Industry Pharmaceuticals
Size Small
Website ckdpharm.com
Index
KOSPI
Chong Kun Dang stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 17-Sep-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
74 46 34 51
Growth
19 6 93 15
Safety
Safety
63 65 34 55
Sentiment
92 76 98 73
360° View
360° View
70 46 85 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
63 88 69 82
Opinions Change
50 26 64 50
Pro Holdings
n/a 64 80 10
Market Pulse
90 76 89 93
Sentiment
92 76 98 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
74 46 34 51
Growth
19 6 93 15
Safety Safety
63 65 34 55
Combined
49 49 50 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
89 84 70 87
Price vs. Earnings (P/E)
50 51 40 51
Price vs. Book (P/B)
70 43 29 39
Dividend Yield
63 34 31 32
Value
74 46 34 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
59 27 21 40
Profit Growth
39 11 89 16
Capital Growth
1 31 84 85
Stock Returns
42 26 93 5
Growth
19 6 93 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
44 43 31 40
Refinancing
64 80 53 71
Liquidity
63 57 45 47
Safety Safety
63 65 34 55

Similar Stocks

Discover high‑ranked alternatives to Chong Kun Dang and broaden your portfolio horizons.

Shimadzu

TYO:7701
Country: Japan
Industry: Electronic Equipment
Size: X-Large
Full Stock Analysis

Cosmo Energy Holdings

TYO:5021
Country: Japan
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

NICE Information Service

KSC:030190
Country: South Korea
Industry: Research & Consulting
Size: Medium
Full Stock Analysis

Hyundai Home Shopping Network

KSC:057050
Country: South Korea
Industry: Internet Retail
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews